Influence of explanatory and confounding variables on HRQoL after controlling for measurement bias and response shift in measurement

References

• Ried LD, Tueth MJ, Taylor MD, Sauer BC, Lopez LM, Pepine CJ. Depressive symptoms in coronary artery disease patients after hypertensive treatment. Ann. Pharmacother. 40, 597–604 (2006).
   Google Scholar
• Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National High Blood Pressure Education Program Coordinating Committee. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289, 2560–2572 (2003).
   PubMed Web of Science ®Google Scholar
• Ried LD, Tueth MJ, Handberg E, Kupfer S, Pepine CJ; INVEST study group. A study of antihypertensive drugs and depressive symptoms (SADD-Sx) in patients treated with a calcium antagonist versus an atenolol hypertension treatment strategy in the International verapamil SR-Trandolapril study (INVEST). Psychosom. Med. 67, 398–406 (2005).
   PubMed Web of Science ®Google Scholar
• Khawaja IS, Westermeyer JJ, Gajwani P, Feinstein RE. Depression and coronary artery disease: the associations, mechanisms, and therapeutic implications. Psychiatry (Edgmont.) 6(1), 38–51 (2009).
   PubMedGoogle Scholar
• Hance M, Carney RM, Freedland KE et al. Depression in patients with coronary artery disease: a 12-month follow up. Gen. Hosp. Psychiatry 18, 61–65 (1996).
   PubMed Web of Science ®Google Scholar
• Ried LD, McFarland BH, Johnson RE, Brody KK. Betablockers and depression: the more the murkier? Ann. Pharmacother. 32, 699–708 (1998).
   Google Scholar
• Ko DT, Hebert PR, Coffey CS, Sedrakyan A, Curtis JP, Krumholz HM. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA 288, 351–357 (2002).
   PubMed Web of Science ®Google Scholar
• Lacy CF, Armstrong LL, Goldman MP, Lance LL. Drug Information Handbook (8th Edition). Lexi-Comp, Hudson, OH, USA (2000–2001).
   Google Scholar
• Avorn J, Everitt DE, Weiss S. Increased antidepressant use in patients prescribed beta-blockers. JAMA 255, 357–360 (1986).
   PubMed Web of Science ®Google Scholar
• Thiessen BQ, Wallace SM, Blackburn JL, Wilson TW, Bergman U. Increased prescribing of antidepressants subsequent to beta-blocker therapy. Arch. Intern. Med. 150, 2286–2290 (1990).
   PubMedGoogle Scholar
• Bright RA, Everitt, DE. Beta-blockers and depression. Evidence against an association. JAMA 267, 1783–1787 (1992).
   PubMedGoogle Scholar
• Gerstman BB, Jolson HM, Bauer M, Cho P, Livingston JM, Platt R. The incidence of depression in new users of beta-blockers and selected antihypertensives. J. Clin. Epidemiol. 49, 809–815 (1996).
   Google Scholar
• Lindberg G, Bingefors K, Ranstam J, Rastam L, Melander A. Use of calcium channel blockers and risk of suicide: ecological findings confirmed in population based cohort study. Br. Med. J. 316, 741–745 (1998).
   PubMed Web of Science ®Google Scholar
• Ahmed S, Mayo N, Wood-Dauphinee S, Hanley J, Cohen S. The structural equation modeling technique did not show a response shift, contrary to the results of the then test and the Individualized approaches. J. Clin. Epidemiol. 58, 1125–1133 (2005).
   PubMed Web of Science ®Google Scholar
• Sprangers MA, Schwartz CE. Integrating response shift into health-related quality of life research: a theoretical model. Soc. Sci. Med. 48, 1507–1515 (1999).
   PubMed Web of Science ®Google Scholar
• Schwartz CE, Sprangers MA. Methodological approaches for assessing response shift in longitudinal health-related quality of life research. Soc. Sci. Med. 48, 1531–1548 (1999).
   PubMed Web of Science ®Google Scholar
• Oort FJ, Visser MRM, Sprangers MAG. Formal definitions of measurement bias and explanation bias clarify measurement and conceptual perspectives on response shift. J. Clin. Epidemiol. 62, 1126–1137 (2009).
   PubMed Web of Science ®Google Scholar
• Rapkin BD, Schwartz CE. Toward a theoretical of quality-of-life appraisal: implications of findings from studies of response shift. Health Qual. Life Outcomes 2, 14 (2004).
   PubMedGoogle Scholar
• King-Kallimanis BL, Oort FJ, Visser MRM, Sprangers MAG. Structural equation modeling of health-related quality-of-life data illustrates the measurement and conceptual perspectives on response shift. J. Clin. Epidemiol. 62, 1157–1164 (2009).
   PubMed Web of Science ®Google Scholar
• Muthén BO. Some uses of structural equation modeling in validity studies: extending IRT to external variables. In: Test Validity. Wainer H, Braun HI ( Eds). Lawrence Erlbaum Associates, Hillsdale, NJ, USA, 213–338 (1988).
   Google Scholar
• Yu YF, Yu AP, Ahn J. Investigating differential item functioning by chronic diseases in the SF-36 health survey: a latent trait analysis using MIMIC models. Med. Care 45(9), 851–859 (2007).
   Google Scholar
• Gandhi PK, Ried LD, Huang IC, Kimberlin CL, Kauf TL. Assessment of response shift using two structural equation modeling techniques. Qual. Life Res. 22(3), 461–471 (2012).
   Google Scholar
• Pepine CJ, Handberg-Thurmond E, Marks RG et al. Rationale and design of the International Verapamil SR /Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension. J. Am. Coll. Cardiol. 32, 1228–1237 (1998).
   PubMed Web of Science ®Google Scholar
• Pepine CJ, Handberg EM, Cooper-DeHoff RM et al. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The international verapamil-trandolapril study (INVEST): a randomized controlled trial. JAMA 290, 2805–2816 (2003).
   PubMed Web of Science ®Google Scholar
• Joint National Committee on Prevention Detection Evaluation and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch. Intern. Med. 157, 2413–2446 (1997).
   PubMed Web of Science ®Google Scholar
• Saris-Baglama RN, Dewey CJ, Chisholm GB, Kosinski M, Bjorner JB, Ware JE. SF-36 Health Outcomes Scoring Software. QualityMetric Incorporated, Lincoln, RI, USA, 1–157 (2004).
   Google Scholar
• Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. The Health Institute, New England Medical Center, Boston, MA, USA (1993).
   Google Scholar
• Sachdev M, Sun JL, Tsiatis AA, Nelson CL, Mark DB, Jollis JG. The prognostic importance of comorbidity for mortality in patients with stable coronary artery disease. J. Am. Coll. Cardiol. l43, 576–582 (2004).
   Google Scholar
• Chirinos JA, Veerani A, Zambrano JP et al. Evaluation of comorbidity scores to predict all-cause mortality in patients with established coronary artery disease. Int. J. Cardiol. 117, 97–102 (2007).
   Google Scholar
• Brown TA. Confirmatory Factor Analysis for Applied Research. Guilford Press, New York, NY, USA (2006).
   Google Scholar
• Barclay-Goddard R, Lix LM, Tate R, Weinberg L, Mayo NE. Response shift was identified over multiple occasions with a structural equation modeling framework. J. Clin. Epidemiol. 62, 1181–1188 (2009).
   Google Scholar
• MacCallum RC, Browne MW, Sugawara HM. Power analysis and determination of sample size for covariance structure modeling. Psychol. Methods 1(2), 130–149 (1996).
   Google Scholar
• Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat. Med. 9, 811–818 (1990).
   PubMed Web of Science ®Google Scholar
• Jöreskog K, Sörbom D. LISREL 8. Scientific Software Internatonal Inc., Lincolnwood, IL, USA (1993).
   Google Scholar
• SAS Institute. SAS Users Guide, Version 9.1. SAS institute, Inc., Cary, NC, USA (2004).
   Google Scholar
• de Graff JC, Ubbink DTh, Kools EJC, Chamuleau SAJ, Jacobs MJHM. The impact of peripheral and coronary artery disease on health-related quality of life. Ann. Vasc. Surg. 16, 495–500 (2002).
   Google Scholar
• Sevinc S, Akyol AD. Cardiac risk factors and quality of life in patients with coronary artery disease. J. Clin. Nurs. 19, 1315–1325 (2010).
   Google Scholar
• Goodwin JS, Black SA, Satish S. Aging versus disease: the opinions of older black, Hispanic, and non-Hispanic white Americans about the causes and treatment of common medical conditions. J. Am. Geriatr. Soc. 47, 973–979 (1999).
   PubMed Web of Science ®Google Scholar
• Levy BR, Slade MD, Kunkel SR, Kasl SV. Longevity increased by positive self perceptions of aging. J. Pers. Soc. Psychol. 83, 261–270 (2002).
   PubMed Web of Science ®Google Scholar
• Norris CM, Ghali WA, Galbraith PD, Graham MM, Jensen LA, Knudtson ML; APPROACH investigators. Women with coronary artery disease report worse health-related quality of life outcomes compared to men. Health Qual. Life Outcomes 2, 21 (2004).
   PubMedGoogle Scholar
• Macintyre S, Ford G, Hunt K. Do women “over-report” morbidity? Men’s and women’s responses to structured prompting on a standard question on long standing illness. Soc. Sci. Med. 48, 89–98 (1999).
   PubMed Web of Science ®Google Scholar
• McCreary DR, Newcomb MD, Sadava SW. Dimensions of the male gender role: a confirmatory analysis in men and women. Sex Roles 39, 81–95 (1998).
   Web of Science ®Google Scholar
• Lenert LA, Treadwell JR, Schwartz CE. Associations between health status and utilities implications for policy. Med. Care 37, 479–489 (1999).
   PubMed Web of Science ®Google Scholar
• Goodwin PJ, Black JT, Bordeleau LJ, Ganz PA. Health-related quality of life measurement in randomized clinical trials in breast cancer – taking stock. J. Natl Cancer Inst. 95(4), 263–281 (2003).
   Google Scholar
• Barclay-Goddard R, Epstein JD, Mayo NE. Response shift: a brief overview and proposed research priorities. Qual. Life Res. 18, 335–346 (2009).
   PubMed Web of Science ®Google Scholar
• Schwartz CE, Ahmed A, Sawatzky R et al. Guidelines for secondary analysis in search of response shift. Qual. Life Res. doi:10.1007/s11136-013-0402-0 (2013) ( Epub ahead of print).
   Google Scholar